231 related articles for article (PubMed ID: 32313013)
1. Multiplex secretome engineering enhances recombinant protein production and purity.
Kol S; Ley D; Wulff T; Decker M; Arnsdorf J; Schoffelen S; Hansen AH; Jensen TL; Gutierrez JM; Chiang AWT; Masson HO; Palsson BO; Voldborg BG; Pedersen LE; Kildegaard HF; Lee GM; Lewis NE
Nat Commun; 2020 Apr; 11(1):1908. PubMed ID: 32313013
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
3. Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.
Hogwood CE; Bracewell DG; Smales CM
Bioengineered; 2013; 4(5):288-91. PubMed ID: 23328085
[TBL] [Abstract][Full Text] [Related]
4. Targeted CHO cell engineering approaches can reduce HCP-related enzymatic degradation and improve mAb product quality.
Dovgan T; Golghalyani V; Zurlo F; Hatton D; Lindo V; Turner R; Harris C; Cui T
Biotechnol Bioeng; 2021 Oct; 118(10):3821-3831. PubMed ID: 34125434
[TBL] [Abstract][Full Text] [Related]
5. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
Goey CH; Bell D; Kontoravdi C
MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
[TBL] [Abstract][Full Text] [Related]
6. The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process.
Hogwood CE; Tait AS; Koloteva-Levine N; Bracewell DG; Smales CM
Biotechnol Bioeng; 2013 Jan; 110(1):240-51. PubMed ID: 22806637
[TBL] [Abstract][Full Text] [Related]
7. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.
Chiu J; Valente KN; Levy NE; Min L; Lenhoff AM; Lee KH
Biotechnol Bioeng; 2017 May; 114(5):1006-1015. PubMed ID: 27943242
[TBL] [Abstract][Full Text] [Related]
8. Model-directed engineering of "difficult-to-express" monoclonal antibody production by Chinese hamster ovary cells.
Pybus LP; Dean G; West NR; Smith A; Daramola O; Field R; Wilkinson SJ; James DC
Biotechnol Bioeng; 2014 Feb; 111(2):372-85. PubMed ID: 24081924
[TBL] [Abstract][Full Text] [Related]
9. Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production.
Budge JD; Knight TJ; Povey J; Roobol J; Brown IR; Singh G; Dean A; Turner S; Jaques CM; Young RJ; Racher AJ; Smales CM
Metab Eng; 2020 Jan; 57():203-216. PubMed ID: 31805379
[TBL] [Abstract][Full Text] [Related]
10. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
Valente KN; Lenhoff AM; Lee KH
Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry.
Zhang Q; Goetze AM; Cui H; Wylie J; Trimble S; Hewig A; Flynn GC
MAbs; 2014; 6(3):659-70. PubMed ID: 24518299
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.
Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC
AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229
[TBL] [Abstract][Full Text] [Related]
13. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
[TBL] [Abstract][Full Text] [Related]
14. Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses.
Hogwood CE; Bracewell DG; Smales CM
Curr Opin Biotechnol; 2014 Dec; 30():153-60. PubMed ID: 25032907
[TBL] [Abstract][Full Text] [Related]
15. Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing.
Valente KN; Levy NE; Lee KH; Lenhoff AM
Curr Opin Biotechnol; 2018 Oct; 53():144-150. PubMed ID: 29414072
[TBL] [Abstract][Full Text] [Related]
16. Targeted capture of Chinese hamster ovary host cell proteins: Peptide ligand binding by proteomic analysis.
Lavoie RA; di Fazio A; Williams TI; Carbonell R; Menegatti S
Biotechnol Bioeng; 2020 Feb; 117(2):438-452. PubMed ID: 31654407
[TBL] [Abstract][Full Text] [Related]
17. Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.
Waldera-Lupa DM; Jasper Y; Köhne P; Schwichtenhövel R; Falkenberg H; Flad T; Happersberger P; Reisinger B; Dehghani A; Moussa R; Waerner T
MAbs; 2021; 13(1):1955432. PubMed ID: 34347561
[TBL] [Abstract][Full Text] [Related]
18. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
Huang Y; Molden R; Hu M; Qiu H; Li N
J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the power of electrophoresis and chromatography: Offline coupling of reverse phase liquid chromatography-capillary zone electrophoresis-tandem mass spectrometry for analysis of host cell proteins in monoclonal antibody producing CHO cell line.
Kumar R; Shah RL; Ahmad S; Rathore AS
Electrophoresis; 2021 Mar; 42(6):735-741. PubMed ID: 33348443
[TBL] [Abstract][Full Text] [Related]
20. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
